Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial

Achieving the low-density lipoprotein cholesterol (LDL-C) goal following an acute coronary syndrome (ACS) is a milestone often missed due to suboptimal adherence to secondary prevention treatments. Whether improved adherence could result in reduced LDL-C levels is unclear. We aimed to evaluate whether an educational-motivational intervention increases long-term lipid-lowering therapy (LLT) adherence and LDL-C goal attainment rate among post-ACS patients.

Source: Atherosclerosis - March 12, 2021 Category: Cardiology Authors: Stefanos Zafeiropoulos, Ioannis Farmakis, Anastasios Kartas, Alexandra Arvanitaki, Areti Pagiantza, Aristi Boulmpou, Athina Tampaki, Diamantis Kosmidis, Vassileios Nevras, Eleftherios Markidis, Ioannis Papadimitriou, Anastasia Vlachou, Konstantinos Arvani Source Type: research